PANEL SESSION

HiFi 101 for biopharma

Insights from an industry panel

How can HiFi sequencing accelerate biopharma R&D?

In this highly popular session, learn how industry leaders from GSK, Pfizer, AstraZeneca, ClareoBio, and UCL are harnessing highly accurate long-read sequencing (HiFi) from PacBio to help solve challenges in vaccine development, gene therapy, antibody discovery, and more.

What you’ll get

  • ✔ A general introduction to HiFi sequencing and its key application areas in drug discovery and development.
  • ✔ Insights from 6 industry experts on how they apply HiFi sequencing in real-world biopharma research—what problems it solves, why they chose it over alternatives, and how it accelerates decision-making.
  • ✔ Guidance on how to access HiFi sequencing through service providers or by bringing instruments in-house.

Browse the panelist lineup below, and register to access the complete session on-demand.

Watch the session to:

  • Understand the unique advantages of HiFi sequencing compared to other sequencing technologies.
  • Discover how highly accurate long reads enable key applications in drug development.
  • Learn how you can access HiFi sequencing through service providers or owning your own instruments.


Register to watch now

By registering on this web page, you are consenting and agreeing to collection and use of your information by PacBio in accordance with its  privacy policy and by ClareoBio in accordance with its privacy policy.

PANELISTS AND TOPICS

Jing Colatat

Jing Colatat, MS

Senior Scientist, Pfizer
Panel topic: Bacterial whole genome sequencing for vaccine development
Luigi Alvarado

Luigi Alvarado, PhD

Associate Director, Molecular Analytics, GSK
Panel topic: mRNA vaccine critical quality attribute characterization
Yang Song

Yang Song, PhD

Associate Principal Scientist, AstraZeneca
Panel topic: HiFi for antibody screening using display technology
Balaji Olety

Balaji Olety, PhD

Former Associate Director at gene therapy company
Panel topic: AAV gene therapy and vector quality
Melissa Smith

Melissa Smith, PhD

CEO, ClareoBio
Panel topic: Immune repertoire sequencing in drug discovery
Emil Gustavsson

Emil Gustavsson, PhD

Senior Research Fellow, UCL Queen Square Institute of Neurology
Panel topic: Targeted Iso-Seq for ASO development
Elizabeth Tseng

Elizabeth Tseng, PhD

Associate Director, Product Marketing, PacBio
Role: Moderator and HiFi technology overview
Nadia Sellami

Nadia Sellami, PhD

Senior Specialist, Segment Marketing, PacBio
Role: Moderator





Austin McKenna
Rushi Panchal
Matt Hestand
Paul Cherng